Come help save democracy!

Tuesday, May 5 | 8-9 pm ET, 5-6 pm PT  Protecting Healthcare and Our Democracy: A conversation with Mandy Cohen, Former Director, Centers for Disease Control and Prevention PLUS former NC Governor Roy Cooper & Dr. Donald Berwick, IHI founder/former president REGISTER & DONATE A matching fund of $70,000 is in effect for this event! This…

Read More

LGBTQ+ Health Policy

This Health Policy 101 chapter explores LGBTQ+ people’s identities and demographics, their experiences with health and health care, including the significant disparities, and the related health policy landscape.

Read More

Chiesi Group Grows Again in Rare Disease With $1.9B KalVista Acquisition

KalVista Pharmaceuticals brings to Chiesi Group the product Ekterly, the first FDA-approved oral drug for acute treatment of swelling attacks from the rare disease hereditary angioedema. Ekterly’s tablet formulation offers a dosing edge compared to injectable HAE medications. The post Chiesi Group Grows Again in Rare Disease With $1.9B KalVista Acquisition appeared first on MedCity…

Read More